Class IITerminatedD-0261-2023
Drug recall · February 8, 2023
Conzerol zero molluscum contagiosum recall
Why: CGMP deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Conzerol zero molluscum contagiosum, Homeopathic treatment for Molluscum Contagiosum, Topical Cream, Net weight 0.78 oz (22g) tube, UPC 8 60322 00180 8, Manufactured by: Dr. Retter EC Warszawska 17, 05-075 Warszawa Poland
- Lots / codes
Lots: 22123 Exp. 01/2024; 21732 Exp. 07/2023
- Quantity
- 21,892 tubes
- Company
- Discovery Pharma LLC, Oviedo, FL
- Distribution
- CA, FL, WA
- Initiated
- November 9, 2022 · Voluntary: Firm initiated
- Classified
- February 1, 2023
- Reported
- February 8, 2023
- Ended
- April 29, 2024
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.